Clinical trial
Study of Pulmonary Rehabilitation In Nintedanib Treated Patients With IPF: Improvements in Activity, Exercise Endurance Time, and QoL
NCT03717012 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Pulmonary Rehabilitation In Nintedanib Treated Patients With IPF: Improvements in Activity, Exercise Endurance Time, and QoL
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- November 15, 2018
- Completion date
- June 10, 2020
- Enrollment
- 19 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.